RedHill Biopharma Ltd. ("RDHL") Corporate Presentation November 2021 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q2 2021 Earnings Conference Call August 26, 2021 8:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - Chief Executive Officer Guy Goldberg - Chief Business Officer Gilead Raday - Chief Operating Officer Rob Jackson - Senior Vice President, Sales and Marketing Micha Ben-Chorin - Chief Financial Officer Rick Scruggs - Chief Commercial Officer Adi Frish - Chief Corporate and Business Development Offic ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation August 2021 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no r ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q1 2021 Earnings Conference Call May 27, 2021 8:30 AM ET Â Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - Chief Executive Officer Micha Ben-Chorin - Chief Financial Officer Rick Scruggs - Chief Commercial Officer Gilead Raday - Chief Operating Officer Guy Goldberg - Chief Business Officer Adi Frish - Chief Corporate and Business Development Officer Rob Jackson - Senior Vice President, Sales and Marketin ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q4 2020 Earnings Conference Call March 18, 2021 8:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - CEO Micha Chorin - CFO Rick Scruggs - Chief Commercial Officer Gilead Raday - COO Guy Goldberg - Chief Business Officer Adi Frish - Chief Corporate and Business Development Officer Rob Jackson - SVP, Sales and Marketing Conference Call Participants Scott Henry - ROTH Capital Ram Selvaraju - H.C. Wai ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation December 2020 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q3 2020 Earnings Conference Call November 12, 2020 8:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations Manager Dror Ben-Asher - Chief Executive Officer Micha Chorin - Chief Financial Officer Rick Scruggs - Chief Commercial Officer Gilead Raday - Chief Operating Officer Guy Goldberg - Chief Business Officer Conference Call Participants Matt Kaplan - Ladenburg David Hoang - SMBC Scott Henry - ROTH Capital Operator Good day ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation November 2020 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation October 2020 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation September 2020 Forward Looking Statement This presentation does not constitute an offer or invitation to sell or issue, or any solicitation of an offer to subscribe for or acquire any of the Company's securities or to participate in any investment in the Company. No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, n ...